These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33615221)

  • 1. High burden of infections caused by ESBL-producing MDR
    San T; Moe I; Ashley EA; San N
    JAC Antimicrob Resist; 2021 Mar; 3(1):dlab011. PubMed ID: 33615221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of CTX-M
    Koirala S; Khadka S; Sapkota S; Sharma S; Khanal S; Thapa A; Khadka DK; Poudel P
    Biomed Res Int; 2021; 2021():9958294. PubMed ID: 34212045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006).
    Zhanel GG; Decorby M; Nichol KA; Baudry PJ; Karlowsky JA; Lagace-Wiens PR; McCracken M; Mulvey MR; Hoban DJ
    Can J Infect Dis Med Microbiol; 2008 May; 19(3):243-9. PubMed ID: 19412382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility profiles and detection of genes mediating extended-spectrum β-lactamase (Esbl) production in escherichia coli isolates from National Hospital, Abuja.
    Enyinnaya SO; Iregbu KC; Jamal WY; Rotimi VO
    Niger J Clin Pract; 2022 Aug; 25(8):1216-1220. PubMed ID: 35975366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal.
    Bhandari R; Pant ND; Poudel A; Sharma M
    BMC Res Notes; 2016 Aug; 9():390. PubMed ID: 27488224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgrouping of ESBL-producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs.
    Valentin L; Sharp H; Hille K; Seibt U; Fischer J; Pfeifer Y; Michael GB; Nickel S; Schmiedel J; Falgenhauer L; Friese A; Bauerfeind R; Roesler U; Imirzalioglu C; Chakraborty T; Helmuth R; Valenza G; Werner G; Schwarz S; Guerra B; Appel B; Kreienbrock L; Käsbohrer A
    Int J Med Microbiol; 2014 Oct; 304(7):805-16. PubMed ID: 25213631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; Decorby MR; McCracken M; Alfa MJ; Mulvey MR; Zhanel GG
    Can J Infect Dis Med Microbiol; 2007 Mar; 18(2):133-7. PubMed ID: 18923714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genotypic comparison of ESBL production by vaginal Escherichia coli isolates from pregnant and non-pregnant women.
    Al-Mayahie SM
    Ann Clin Microbiol Antimicrob; 2013 Apr; 12():7. PubMed ID: 23617811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt.
    Hassuna NA; Khairalla AS; Farahat EM; Hammad AM; Abdel-Fattah M
    Sci Rep; 2020 Feb; 10(1):2772. PubMed ID: 32066805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
    Woodford N; Kaufmann ME; Karisik E; Hartley JW
    J Antimicrob Chemother; 2007 Jan; 59(1):106-9. PubMed ID: 17090553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
    Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
    J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integron-mediated multidrug resistance in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from fecal specimens in Egypt.
    Elsherif RH; Ismail DK; El-Kholy YS; Gohar NM; Elnagdy SM; Elkraly OA
    J Egypt Public Health Assoc; 2016 Jun; 91(2):73-9. PubMed ID: 27455084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background.
    Franiczek R; Sobieszczańska B; Turniak M; Kasprzykowska U; Krzyzanowska B; Jermakow K; Mokracka-Latajka G
    Adv Clin Exp Med; 2012; 21(2):187-92. PubMed ID: 23214282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of extended-spectrum beta-lactamase-producing
    Siriphap A; Kitti T; Khuekankaew A; Boonlao C; Thephinlap C; Thepmalee C; Suwannasom N; Khoothiam K
    Front Cell Infect Microbiol; 2022; 12():955774. PubMed ID: 36004324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.
    Al-Mayahie S; Al Kuriashy JJ
    J Infect Dev Ctries; 2016 Jun; 10(6):575-83. PubMed ID: 27367005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of
    Abrar S; Ain NU; Liaqat H; Hussain S; Rasheed F; Riaz S
    Antimicrob Resist Infect Control; 2019; 8():80. PubMed ID: 31139363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.